"Clinical trials found that patients receiving the recommended daily dose of Topamax experienced a significant reduction in monthly migraine attacks, compared with placebo. Elderly people may be at greater risk for side effects such as drowsiness and dizziness while using this drug. Topamax is indicated for the prophylaxis of migraine headaches."